Mirae Asset TIGER USD Money Market Active Fund (329750)

Overview

Promimic AB, based in Mölndal, Sweden, operates within the biomaterials sector, focusing on enhancing osseointegration in orthopedic and dental implants. Since its foundation in 2004, the company has dedicated itself to the development and commercialization of innovative technologies aimed at improving the integration of surgical implants with bone tissue. Its mission involves advancing the field of biomaterials through research and development of surface modifications that facilitate better outcomes for patients requiring implants.

Products and Services

• HAnano Surface Technology:

This proprietary technology developed by Promimic stands at the forefront of their offerings. The HAnano surface is engineered to foster improved osseointegration, which is the direct structural and functional connection between living bone and the surface of a load-bearing artificial implant. This nanometer-thin layer mimics the natural bone structure, promoting bone growth and improving the stability of implants. Utilized in both orthopedic and dental fields, it represents a significant advancement in implantology by combining key attributes such as biocompatibility, mechanical stability, and enhanced bone bonding capabilities into a single surface treatment.